[ET Net News Agency, 27 February 2024] EVEREST MED-B (01952) rose 8.5% to HK$21.1.
It hits an intra-day high of HK$21.4, hitting an 1-month high, and an intra-day low of
HK$19.72. The total shares traded was 1.31 million, with a value of HK$27.18m. The active
buy/sell ratio is 77:23, with net buying turnover of HK$14.01m. CHINA MERCHANTS SEC (HK)
accounts for greatest net responsive buying turnover of HK$315,000, with volume weighted
average price of HK$20.543. CHINA INNOVATION MARKET SER accounts for greatest net
responsive selling turnover of HK$2.79m, with volume weighted average price of HK$20.632.
Basic Information
=================
---------------------------------
Nominal 21.100 % Chg +8.54%
High 21.400 Low 19.720
Shares Tr 1.31m Turnover 27.18m
10-D SMA 18.512 %H.V 93.449
20-D SMA 17.301 VWAP 20.729
50-D SMA 18.288 RSI14 63.718
---------------------------------
Status: Hitting an 1-month high, active buy/sell ratio is 77:23, with net buying turnover
of HK$14.01m
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
EVEREST MED-B (01952) 21.10 +8.54
GENSCRIPT BIO (01548) 15.76 +2.47
INNOVENT BIO (01801) 40.85 +3.81
JXR (01951) 2.49 +1.22
WUXI BIO (02269) 19.14 +2.03
WUXI APPTEC (02359) 50.00 +1.11
BEIGENE (06160) 98.60 +5.45
CANSINOBIO (06185) 18.02 -0.33
ZAI LAB (09688) 16.52 +5.36
AKESO (09926) 46.25 +0.76
---------------------------------------------
(ed)